CF
BIIB icon

Corebridge Financial’s Biogen BIIB Stock Holding History

Corebridge Financial’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-44,254
Closed -$6.06M – 358
2025
Q1 		$6.06M Sell
44,254
-1,238
-3% -$177K 0.03% 600
2024
Q4 		$6.96M Sell
45,492
-1,710
-4% -$288K 0.04% 563
2024
Q3 		$9.15M Sell
47,202
-1,206
-2% -$252K 0.05% 449
2024
Q2 		$11.2M Buy
+48,408
New +$10.5M 0.06% 321

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Corebridge Financial's BIIB Position: Q2 2025 in Review

Corebridge Financial sold out of Biogen (BIIB) in Q2 2025, closing a stake of 44,254 shares — an estimated $6.06M sold.

Corebridge Financial first reported a position in BIIB in Q2 2024 and held it in 4 quarters. The position peaked at $11.2M in Q2 2024. 866 funds tracked by Wall St. Rank hold BIIB as of Q2 2025.

  • Corebridge Financial reported no remaining Biogen position as of Q2 2025 after selling out during the quarter.
  • Corebridge Financial sold 44,254 Biogen shares in Q2 2025, an estimated $6.06M.
  • Corebridge Financial first reported a position in Biogen in Q2 2024 and held it in 4 quarters.
  • Corebridge Financial's Biogen position peaked at $11.2M in Q2 2024.
  • 866 funds tracked by Wall St. Rank held Biogen as of Q2 2025.

Based on Corebridge Financial's 13F filing for Q2 2025, filed 12 Aug 2025.